Sponsor Confidential Information has the meaning set forth in Section 5.06(a).
Sponsor Confidential Information means any information relating to (1) the proprietary, nonpublic inputs to the Base Case Projections, (2) the Project Documents, (3) the Construction Plans, and (4) the Financial Statements of the Sponsor Parties.
Sponsor Confidential Information shall have the meaning set forth in Section 7(a).
Examples of Sponsor Confidential Information in a sentence
The foregoing will not be construed to prevent the Parties from identifying the Sites, Site Principal Investigator, and Protocol Principal Investigator to Regulatory Authorities in connection with Sponsor Confidential Information, Study results, the development and commercialization of the Study Drug and pursuit of patent protection related thereto, or otherwise to comply with Applicable Law.
More Definitions of Sponsor Confidential Information
Sponsor Confidential Information is defined as information and material that is regarded by SPONSOR as confidential and proprietary to SPONSOR and received from SPONSOR, and which is designated as confidential or which by its nature may reasonably be considered to be confidential. WSU shall limit access the SPONSOR Confidential Information to those of its employees with a need to have access to such SPONSOR Confidential Information. WSU shall not disclose SPONSOR Confidential Information to any third party and shall use SPONSOR Confidential Information solely for the purpose of conducting the Program. WSU's obligations under this Section 8 shall be limited to a period of five (5) years from receipt of SPONSOR Confidential Information. WSU shall not have any obligation of confidentiality with respect to any SPONSOR Confidential Information that:
Sponsor Confidential Information means (a) any and all scientific, technical, business, regulatory, or financial information in whatever form (written, oral, electronic or visual) that is delivered or otherwise disclosed to HJF, CRO, RedHill, Sites, Site Principal Investigators, or Principal Investigator (“Recipient”), by or on behalf of HJF or RedHill or its designees (“Discloser”) for the purpose of conducting the Study, including the Protocol, the financial terms of this Agreement; (b) all approvals and correspondence with or from an IRB or other entities with oversight responsibilities for the Study, including ethics committees or data safety monitoring committees, all Study correspondence, all Study Drug accountability forms, and all CRFs (collectively, the “Study Documentation”); (c) all Study Data and (d) information that a reasonable person familiar with the Study would consider to be confidential or proprietary from the context or circumstances of disclosure; provided, however, that (i) Study Drug Sponsor and HJF are co-exclusive owners of all Study Data pursuant to Section 9.2 (Study Data and Materials) and are free to use their own Confidential Information subject to Section 7 (Publication); (ii) Protocol Principal Investigator may use and/or publish Study Data solely in accordance with this Agreement; (iii) Sites and Site Principal Investigators may use and/or publish Study Data solely in accordance with the applicable Site contract, substantially similar to those terms and conditions applicable to the Parties under this Agreement; (iv) the U.S. Government may use and/or publish Study Data and Technical Data in accordance with the OTA; and (v) a Discloser is free to use its own Sponsor Confidential Information for which it is the Discloser.
Sponsor Confidential Information means all information (and all tangible and intangible embodiments thereof) that is disclosed by or on behalf of the Sponsor to the Institution or the Investigator, whether or not labeled “confidential”, including, without limitation, any scientific, technical, trade or business information possessed or obtained by, developed for or given to Sponsor which is treated by Sponsor as confidential or proprietary. “Sponsor Confidential Information” includes, without limitation, the Protocol, completed CRFs, signed Informed Consent Forms, Study Device, accountability forms, IRB approvals and correspondence, Study correspondence and the Results; see, however, sections 5.4 and 6, below, for Institution’s and Investigator’s rights to use and publish Results. 5.1.1
Sponsor Confidential Information includes, without limitation, any and all of the clinical data and research results, technical and non-technical data, formulae, ideas, know-how, materials, methods, operational information, patent applications, plans, procedures, pre-clinical data and results, processes, product information, projections, specifications, standards, strategies, technical information, techniques, trade secrets, tools, or other clinical, technical or business information. INSTITUTION shall treat Study Data, the Protocol, SPONSOR’s informed consent samples and investigators’ brochure(s) as SPONSOR Confidential Information, whether or not marked as confidential.
Sponsor Confidential Information means all information (and all tangible and intangible embodiments thereof) that is disclosed by or on behalf of the Sponsor to the Institution or the Investigator, whether or not labeled “confidential”, including, without limitation, any scientific, technical, trade or business information possessed or obtained by, developed for or given to Sponsor which is treated by Sponsor as confidential or proprietary. “Sponsor Confidential Information” includes, without limitation, the Protocol, completed CRFs, signed Informed Consent Forms, Study Device, accountability forms, IRB approvals and correspondence, Study correspondence and the Results; see, however, sections studie mohly být zařazeny. Formuláře pro sběr dat subjektů hodnocení budou předány zadavateli xxxx xxx pověřeným osobám ve formě nebo na elektronickém médiu dle pokynů zadavatele xxxx xxx pověřených osob. Na žádost zadavatele xxxx xxx pověřených osob opraví zdravotnické zařízení nebo zkoušející neprodleně veškeré chyby a/nebo opomenutí ve formulářích pro sběr dat subjektů hodnocení týkajících se studie a zpřístupní zadavateli a/xxxx xxx pověřeným osobám opravené formuláře a podpůrné záznamy k další kontrole. Zkoušející souhlasí s xxx, že podepíše prohlášení uvedené v záznamech studie každého subjektu hodnocení nebo ve formuláři pro sběr dat subjektů hodnocení, které potvrzuje, že provedl kontrolu formuláře pro sběr dat subjektů hodnocení a ověřil, že informace v něm obsažené jsou přesné a obsahují léčbu, péči a příhody, které proběhly v rámci účasti daného subjektu hodnocení ve studii. 4.8
Sponsor Confidential Information shall not include information or materials that: (i) were in the possession of the CDAC before receipt from the Sponsor; (ii) were or become available to the public through no fault of the CDAC; (iii) have been received in good faith by the CDAC from a third party who does not owe a duty of confidentiality to the Sponsor; (iv) have been independently developed by the CDAC without any use of Sponsor Confidential Information; or (v) are required to be disclosed by law.
Sponsor Confidential Information means: (a) all Confidential Information whether disclosed in writing, verbally, by way of sample or by any other means and whether directly or indirectly, by or on behalf of Sponsor to Fujifilm Group or Subcontractors in connection with this Agreement, including Background Intellectual Property of Sponsor and Sponsor Deliverables; and (b) Sponsor Inventions, except to the extent Fujifilm Confidential Information is incorporated into Fujifilm Deliverables. [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.